2. Unwillingness to enroll in a clinical research protocol governing admission and management of exposure to, or infection with, a biodefense select agent, an agent of bioterrorism concern, a naturally-occurring pathogen in the environment, or an agent of emerging infectious disease that is conducted at the NIH Clinical Center.